WEIGHT & METABOLISM
GLP-1 receptor agonist protocols built to reduce appetite, support insulin response, and drive sustainable, clinician-guided weight loss — not a crash diet.
The peptides behind it.
Every protocol is built and reviewed by a licensed clinician — these are the peptides most commonly used for weight & metabolism goals.
Semaglutide
A GLP-1 receptor agonist that mimics a natural gut hormone to regulate appetite and slow gastric emptying, supporting gradual, sustained weight loss alongside lifestyle changes.
Tirzepatide
Targets both the GLP-1 and GIP receptors, which for many patients translates to a stronger metabolic and appetite-suppressing effect than a single-receptor agonist.
What patients look for.
Reduced appetite
Most patients notice fewer food cravings within the first couple of weeks on a titrating dose.
Gradual, sustained loss
Protocols start low and titrate slowly, with visible change typically building over 8–12 weeks.
Metabolic support
Improved insulin response is part of how GLP-1s work, not just appetite suppression.